Exercise Training for Breast Cancer Survivors
Trial Summary
Will I have to stop taking my current medications?
The trial does not require you to stop taking your current medications. In fact, certain breast cancer treatments like endocrine therapy and other specified medications are allowed during the study.
What data supports the effectiveness of the treatment Exercise training for breast cancer survivors?
Is exercise training safe for breast cancer survivors?
Research shows that exercise, including weightlifting and aerobic activities, is generally safe for breast cancer survivors. Studies have found that physical activity can be performed safely during and after treatment, with benefits like improved fitness and quality of life, and low rates of injury.14678
How does exercise training differ from other treatments for breast cancer survivors?
Exercise training is unique because it focuses on improving physical, mental, and social well-being through regular physical activity, rather than using medication or surgery. It involves moderate-intensity aerobic and resistance exercises, which can help reduce fatigue, improve quality of life, and potentially lower the risk of cancer recurrence.1491011
What is the purpose of this trial?
There are more than 3.8 million breast cancer survivors in the United States and cancer survivors have a higher risk of cardiovascular disease (CVD) due to chemotherapy than adults without cancer. Cardiovascular rehabilitation can be an effective strategy to decrease the incidence of CVD and its risk factors in this population. The proposed study may help to examine the effect of a novel exercise intervention on cardiovascular rehabilitation in breast cancer survivors.
Research Team
Demetra Christou, PhD
Principal Investigator
University of Florida
Eligibility Criteria
This trial is for female breast cancer survivors, aged 40-80, who've completed chemotherapy for primary invasive non-metastatic breast cancer (stages I-III) 6-18 months prior. They must be cleared by a clinician and not engage in regular intense exercise. Excluded are those with severe obesity, ongoing radiation or surgery plans, recent other treatments or interventions that could affect results, and certain cardiovascular conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive instruction on using a Concept 2 RowErg and engage in moderate-intensity exercise for 50 minutes, 3 days per week, for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of global longitudinal strain and brachial FMD
Treatment Details
Interventions
- Exercise training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor